Relative Safety of Gemfibrozil and Fenofibrate in the Absence of Concomitant Cerivastatin Use Holoshitz N et al. - The safety profiles of fibrates differ, with a higher rate of liver-related AERs associated with fenofibrate and a higher rate of muscle-related AERs associated with gemfibrozil. Rates of all AERs and serious AERs were higher with fenofibrate, but well within the range observed with commonly used lipid-altering medications [more...]
